Emergent BioSolutions Inc. (EBS)

NYSE: EBS · Real-Time Price · USD

8.79

-0.12 (-1.35%)

At close: Aug 13, 2025, 4:00 PM

8.80

+0.01 (0.11%)

Pre-market: Aug 14, 2025, 8:43 AM EDT

Emergent BioSolutions Market Cap

Emergent BioSolutions has a market cap or net worth of $468.96 million as of August 14, 2025. Its market cap has decreased by -39.41% in one year.

Market Cap

468.96M

Enterprise Value

877.76M

1-Year Change

-39.41%

Ranking

#3063

Market Cap Chart

Since November 15, 2006, Emergent BioSolutions's market cap has increased from $320.80M to $468.96M, an increase of 46.18%. That is a compound annual growth rate of 2.04%.

Market Cap History

Date	Market Cap	% Change
Aug 13, 2025	469.00M	-9.46%
Dec 31, 2024	518.00M	316.06%
Dec 29, 2023	124.50M	-78.87%
Dec 30, 2022	589.20M	-74.81%
Dec 31, 2021	2.34B	-50.75%
Dec 31, 2020	4.75B	70.50%
Dec 31, 2019	2.79B	-7.78%
Dec 31, 2018	3.02B	57.00%
Dec 29, 2017	1.92B	44.63%
Dec 30, 2016	1.33B	-14.64%
Dec 31, 2015	1.56B	52.38%
Dec 31, 2014	1.02B	22.29%
Dec 31, 2013	836.10M	45.38%
Dec 31, 2012	575.10M	-5.00%
Dec 30, 2011	605.40M	-25.67%
Dec 31, 2010	814.50M	94.58%
Dec 31, 2009	418.60M	-46.42%
Dec 31, 2008	781.20M	419.07%
Dec 31, 2007	150.50M	-50.82%
Dec 29, 2006	306.00M	-4.61%

View and export this data all the way back to 2006. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Eli Lilly and Company	574.04B
Johnson & Johnson	416.11B
AbbVie	350.91B
UnitedHealth Group	236.90B
AstraZeneca	232.33B
Novartis AG	230.64B
Abbott Laboratories	228.03B
Novo Nordisk	223.00B

Market Cap Rankings